1 Followers USX:EXAS - Exact Sciences Corp. (USD 67.06) Exact Sciences Corp.
Sector: Health Technology, Industry: Medical Specialties
Add to Watchlist

Yahoo Finance

USD 67.06    +0.690 (+1.04%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

9 Apr 2020


9 Apr 2020

Day Change: 0.690 (1.04%)

52 Wk Range: 35.2512 - 123.99

Day's Range: 66.62 - 69.53

Last Volume: 1,804,183

Current Yield: 0%

Projected Yield: 0%

Open: USD 68.05

9 Apr 2020

Metric EXAS S.Median
Beta 1.39 0.84
VaR 40 25.23
E.Shortfall 53.55 45.03
Liquidity 2.12M 95.2K


9 Apr 2020

PE: -38.559

Market Cap: 8.4B

Price Over Book: 10.858

Price Over Sales: 16.03

Return On Assets: -12.4%

Return On Equity: -28.2%

Price Over NAV: [Friends Only]


CEO: Kevin T. Conroy

Headquarters: MADISON

Employees: 1,977

Sector: Health Technology

Industry: Medical Specialties

Useful Links


Exact Sciences Corporation, a molecular diagnostics company, focuses on developing products for the early detection and prevention of various cancers in the United States. The company develops the Cologuard, a non-invasive stool-based DNA screening test for the early detection of colorectal cancer and pre-cancer. It has a collaboration, license, and purchase agreement with Genzyme Corporation; and license agreement with MAYO Foundation for Medical Education and Research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.